DECIPHERING DRUG RESISTANCE MECHANISMS IN TRIPLE-NEGATIVE BREAST CANCER THROUGH CROSS-PLATFORM INTEGRATION OF SCRNA-SEQ,EPIGENOMICS, AND CHEMOINFORMATICSINTRODUCTION. Clinical and Health Research Exploration, [S. l.], v. 2, n. 01, p. 64–85, 2024. Disponível em: https://chre.online/index.php/CHRE/article/view/21. Acesso em: 4 apr. 2026.